How Home Diagnostic Tools Will Alter the Future of Wet Age-Related Macular Degeneration

SriniVas R. Sadda, MD


May 06, 2022

SriniVas R. Sadda, MD, looks to the future at the dawn of home diagnostics and home monitoring for patients with exudative age-related macular degeneration (wet AMD) through the promise and anticipated approval of at-home optical coherence tomography (OCT). Dr Sadda sees home OCT as a practice-changing advance in mitigating the burden of frequent office visits for patients and their families and as a part of the treat-and-extend approach, where intervals between office visits can be extended.

Dr Sadda envisions a future in which patients can scan themselves at home using OCT technology and pick up the earliest signs of increased disease activity. Dr Sadda anticipates that with at-home monitoring, early indications of conversion from high-risk dry AMD to wet AMD can be detected, allowing patients to initiate treatment at the first signs of vision loss.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.